Home › Idiopathic Thrombocytopenic Purpura › Louisiana
Idiopathic Thrombocytopenic Purpura clinical trials in Louisiana
4 studies for Idiopathic Thrombocytopenic Purpura are looking for participants at sites in Louisiana.
Cities in Louisiana
A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)
- Pontchartrain Cancer Center, Covington
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT07421167A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
- Ochsner Clinic Foundation, New Orleans
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT06721013Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment
- Tulane University Health Sciences Center - Tulane Avenue-Investigational Site Number: 8400011, New Orleans
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jun 22, 2026 · NCT07007962A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
- Tulane University, New Orleans
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 1, 2026 · NCT06544499From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.